Listed

Xtant Medical Holdings, Inc.: Form 10-Q for the period ended Sep 30, 2019

Filed with the SEC on Nov 7, 2019 and accepted by EDGAR at Nov 7, 2019, 07:31 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2019-09-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2019-07-01 to 2019-09-30$15.7mus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Revenue9 months2019-01-01 to 2019-09-30$47.7mus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Cost of revenue3 months2019-07-01 to 2019-09-30$5.2mus-gaap:CostOfGoodsAndServicesSold
Cost of revenue9 months2019-01-01 to 2019-09-30$16.5mus-gaap:CostOfGoodsAndServicesSold
Gross profit3 months2019-07-01 to 2019-09-30$10.5mus-gaap:GrossProfit
Gross profit9 months2019-01-01 to 2019-09-30$31.2mus-gaap:GrossProfit
Research and development3 months2019-07-01 to 2019-09-30$203.0kus-gaap:ResearchAndDevelopmentExpense
Research and development9 months2019-01-01 to 2019-09-30$675.0kus-gaap:ResearchAndDevelopmentExpense
Operating income3 months2019-07-01 to 2019-09-30−$705.0kus-gaap:OperatingIncomeLoss
Operating income9 months2019-01-01 to 2019-09-30−$1.9mus-gaap:OperatingIncomeLoss
Interest expense3 months2019-07-01 to 2019-09-30$1.2mus-gaap:InterestExpense
Interest expense9 months2019-01-01 to 2019-09-30$4.5mus-gaap:InterestExpense
Income tax3 months2019-07-01 to 2019-09-30$23.0kus-gaap:IncomeTaxExpenseBenefit
Income tax9 months2019-01-01 to 2019-09-30$68.0kus-gaap:IncomeTaxExpenseBenefit
Net income3 months2019-07-01 to 2019-09-30−$1.9mus-gaap:NetIncomeLoss
Net income9 months2019-01-01 to 2019-09-30−$6.6mus-gaap:NetIncomeLoss
Diluted EPS3 months2019-07-01 to 2019-09-30−$0.14us-gaap:EarningsPerShareDiluted
Diluted EPS9 months2019-01-01 to 2019-09-30−$0.50us-gaap:EarningsPerShareDiluted
Basic EPS3 months2019-07-01 to 2019-09-30−$0.14us-gaap:EarningsPerShareBasic
Basic EPS9 months2019-01-01 to 2019-09-30−$0.50us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2019-07-01 to 2019-09-3013,161,762 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)9 months2019-01-01 to 2019-09-3013,164,694 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow9 months2019-01-01 to 2019-09-30−$342.0kus-gaap:NetCashProvidedByUsedInOperatingActivities
Cash and equivalentsAt period end2019-09-30$5.7mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2019-09-30$31.6mus-gaap:AssetsCurrent
Total assetsAt period end2019-09-30$43.0mus-gaap:Assets
Current liabilitiesAt period end2019-09-30$9.1mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2019-09-30$85.9mus-gaap:Liabilities
Long-term debtAt period end2019-09-30$75.0mus-gaap:LongTermDebtNoncurrent
Shareholders' equityAt period end2019-09-30−$42.9mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001493152-19-016584. Last ingested by Listed: Oct 24, 2026, 15:08 ET. Listed shows no prices and gives no investment advice.